Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Parissa Tabrizian"'
Autor:
Michela Assalino, Giulio Cesare Vitali, Marco Bongini, Neil Mehta, Sylvain Terraz, Enrico Gringeri, Laura Kulik, Axel Andres, Philippe Compagnon, Quirino Lai, M. Grat, Raffaele Brustia, Christian Toso, Thierry Berney, Pietro Majno, Olivier Scatton, Vatche G. Agopian, Neeta Vachharajani, Vincenzo Mazzaferro, Parissa Tabrizian, Krzysztof Zieniewicz, Umberto Cillo, William C. Chapman
Publikováno v:
Transplant International. 33:567-575
Macrovascular invasion is considered a contraindication to liver transplantation for hepatocellular carcinoma (HCC) due to a high risk of recurrence. The aim of the present multicenter study was to explore the outcome of HCC patients transplanted aft
Autor:
Quirino Lai, Karim J. Halazun, M.B. Majella Doyle, Federico Aucejo, Jans Mittler, Cristiano Quintini, Francis Y. Yao, Jean C. Emond, Benedikt Schaefer, Jan Lerut, Neil Mehta, Robert S. Brown, Tommy Ivanics, Armin Finkenstedt, Andre Gorgen, Samuele Iesari, Parissa Tabrizian, Maria Hoppe-Lotichius, Benjamin Samstein, Massimo Rossi, Kaveh Hajifathalian, William C. Chapman, Gonzalo Sapisochin, Kazunari Sasaki, Vatche G. Agopian, Gagan Brar, Marc Najjar, Russell Rosenblatt, Gianluca Mennini
Publikováno v:
JAMA Surgery, Vol. 156, no. 6, p. 559-567 (2021)
IMPORTANCE: Accurate preoperative prediction of hepatocellular carcinoma (HCC) recurrence after liver transplant is the mainstay of selection tools used by transplant-governing bodies to discern candidacy for patients with HCC. Although progress has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f06a3fcd5ae80306a525ada9b0c92108
https://hdl.handle.net/2078.1/246045
https://hdl.handle.net/2078.1/246045
Publikováno v:
Liver Transplantation
The COVID-19 pandemic has dramatically impacted the transplant community worldwide 1-3 . Uncertainty and a lack of treatment protocols have resulted in a considerable reduction in, if not cessation of, transplantations. Wait-list mortality remains hi
Autor:
Thomas D. Schiano, Paolo Boffetta, Philipp K. Haber, Myron Schwartz, Parissa Tabrizian, Behnam Saberi, Josep M. Llovet, Tatyana Kushner, Douglas T. Dieterich, Gaurav Kakked, Amreen Dinani, Marc Puigvehí, Amon Asgharpour, Scott L. Friedman, Ahmet Gurakar, Dana Hashim
Publikováno v:
Am J Transplant
Hepatitis C virus infection has been the most common etiology in HCC-related liver transplantation (LT). Since 2014, direct-acting antivirals (DAAs) have dramatically improved HCV cure. We aimed to study the changing pattern of etiologies and impact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e09de56036a919d7ff66a4dfce92971
https://hdl.handle.net/11585/732681
https://hdl.handle.net/11585/732681
Autor:
Marcelo Facciuto, Chiara Rocha, Ganesh Gunasekaran, Sander Florman, Matthew L. Holzner, Parissa Tabrizian, Kezhen Fei, Fatemeh P. Parvin-Nejad, Myron Schwartz
Publikováno v:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation SocietyReferences. 26(7)
Mixed hepatocellular-cholangiocarcinoma (HCC-CC) is a biphenotypic liver cancer thought to have unfavorable tumor biology and a poor prognosis. Surgical outcomes of HCC-CC remain unclear. We aimed to evaluate the clinical characteristics and surgical
Autor:
Swan N. Thung, Sander Florman, Joseph J. Titano, Edward Kim, Myron Schwartz, Parissa Tabrizian, Ismail Labgaa, Emmanuel Melloul
Publikováno v:
HPB, vol. 21, no. 11, pp. 1497-1504
The benefit of transarterial radioembolization (TARE) in patients with unresectable hepatocellular carcinoma (HCC) is increasingly evidenced. However, data on outcome of liver transplantation or resection after TARE remain scarce. This study aimed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b86ee2e757be6c158f7270de64fea4b0
https://serval.unil.ch/notice/serval:BIB_898C72221CB6
https://serval.unil.ch/notice/serval:BIB_898C72221CB6
Publikováno v:
Surgery. 163:698-702
Resection remains the treatment of choice achieving 5-year survival rates of 22% to 40%. The aim of this analysis was to examine the outcomes of patients with solitary ≤5 cm intrahepatic cholangiocarcinoma.A retrospective chart review was performed
Autor:
Jeron Zerillo, Samuel DeMaria, Hung-Mo Lin, Sang Kim, David B. Wax, Parissa Tabrizian, Sander Florman, Jiawen Li, Dennis E. Feierman, Bryan Hill, Ashley So, Natalie K. Smith
Publikováno v:
Clinical Transplantation. 33:e13473
During liver transplantation, the patient is at risk of developing progressive lactic acidosis. Following reperfusion, correction of acidosis may occur. In some patients, acidosis will worsen, a phenomenon referred to as persistent acidosis after rep
Autor:
David B. Wax, Bryan Hill, Hung-Mo Lin, Jessica A. Zerillo, Myron Schwartz, Samuel DeMaria, Parissa Tabrizian
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 42(10)
Background Studies have suggested that blood loss can be reduced during liver resection by monitoring and maintaining low central venous pressure (CVP) through fluid restriction or other means, but such a strategy carries risks to the patient includi